THIS IS A DOCUMENT BUNDLE.

A bundle is a pre-defined set of documents. By purchasing the document bundle as a whole, you achieve significant savings from purchasing the documents individually. See full details below.

BUNDLE DESCRIPTION

As the pharma industry evolves, it's important to know you are basing your decisions on analysis that reflects the very latest trends and issues. With event-sensitive analysis, you can build your strategy based on analysis and forecasts that are reliable and accurate, to give you the tools to rapidly respond to changes across key diseases areas, companies and drugs.

Evaluate your drug's clinical and commercial potential against related treatments based on emerging clinical trial results and treatment guidelines.

Prioritize market opportunities: Assess revenue potential, competitive threats, market catalysts, and untapped product development opportunities with most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends.

Identify unmet needs: Gauge the relative strength of upcoming drugs with our drug comparator tool. Identify untapped opportunities.

What's Included

INTRODUCTION
1. Key Findings
2. Market Share of Drug Classes in 2015 and 2025
3. Disease Market SWOT Analysis
ETIOLOGY AND PATHOPHYSIOLOGY
1. Key Findings
2. Expert Insight
3. Disease Overview
4. Disease Pathophysiology
5. Etiology
6. Pathophysiology
KEY PATHWAYS AND DRUG TARGETS
MARKET OUTLOOK
1. Key Findings
2. Expert Insight
3. Market Overview
4. What Factors Are Driving the Market
5. What Factors Are Constraining the Market

THERE ARE 5 DOCUMENTS ARE IN THIS BUNDLE:

	Pharma Disease Insight: Colorectal Cancer Colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025 in the seven major pharmaceutical markets under study. Growth will be... [read more] View Details Individual Price: $99.00
	Pharma Disease Insight: Gastric Cancer In 2015, major-market sales totaled $1.2 billion for gastric and gastroesophageal junction (GEJ) adenocarcinoma. We expect that major-market sales will rapidly increase... [read more] View Details Individual Price: $99.00
	Pharma Disease Insight: Glioma Yielding an mPFS of 6.9 months and MOS of 14.6 months, the Stupp regimen has been the efficacy yardstick and standard treatment protocol followed for newly diagnosed... [read more] View Details Individual Price: $99.00
	Pharma Disease Insights: Multiple Myeloma The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025.... [read more] View Details Individual Price: $99.00
	Pharma Disease Insight: Breast Cancer (Oncology) The breast cancer therapy market was the largest in oncology across the major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) in 2015... [read more] View Details Individual Price: $99.00

Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right.

Pharma Disease Insights: Oncology

Sold by BigPharma2000 (this author has 41 documents)

$495.00 (40% discount)

$299.00

ALL FEES INCLUDED

Add to Cart

This business document is categorized under the function(s):

Strategy, Marketing, & Sales

It applies to Healthcare & Life Sciences

Purchase includes lifetime product updates. After your purchase, you will receive an email to download the documents in this bundle.

Initial upload date (first version): Jun 13, 2017

Ask the Author a Question

Must be logged in Click here to log in

CUSTOMER TESTIMONIALS

"As a niche strategic consulting firm, Flevy and FlevyPro frameworks and documents are an on-going reference to help us structure our findings and recommendations to our clients as well as improve their clarity, strength, and visual power. For us, it is an invaluable resource to increase our impact and value."

– David Coloma, Consulting Area Manager at Cynertia Consulting

"FlevyPro provides business frameworks from many of the global giants in management consulting that allow you to provide best in class solutions for your clients."

– David Harris, Managing Director at Futures Strategy

"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so many challenges and there is the need to make the right decisions in a short time, with so much scattered information, we are fortunate to have Flevy. Flevy investigates, selects, and puts at our disposal the best of the best to help us be successful in our work."

– Omar Hernán Montes Parra, CEO at Quantum SFE

"As a consultant requiring up to date and professional material that will be of value and use to my clients, I find Flevy a very reliable resource.

The variety and quality of material available through Flevy offers a very useful and commanding source for information. Using Flevy saves me time, enhances my expertise and ends up being a good decision."

– Dennis Gershowitz, Principal at DG Associates

"As an Independent Management Consultant, I find Flevy to add great value as a source of best practices, templates and information on new trends. Flevy has matured and the quality and quantity of the library is excellent. Lastly the price charged is reasonable, creating a win-win value for the customer, Flevy and the various authors. This is truly a service that benefits the consulting industry and associated clients. Thanks for providing this service. "

– Jim Schoen, Principal at FRC Group

"As a young consulting firm, requests for input from clients vary and it's sometimes impossible to provide expert solutions across a broad spectrum of requirements. That was before I discovered Flevy.com.

Through subscription to this invaluable site of a plethora of topics that are key and crucial to consulting, I have been able to exceed expectations and deliver quality advice and solutions to my clients. The quality and expertise of the authors are exemplary and gives me great confidence to use as part of my service offerings.

I highly recommend this company for any consultant wanting to apply international best practice standards in their service offerings. "

– Nishi Singh, Strategist and MD at NSP Consultants

"I have used FlevyPro for several business applications. It is a great complement to working with expensive consultants. The quality and effectiveness of the tools are of the highest standards."

– Moritz Bernhoerster, Global Sourcing Director at Fortune 500

"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor the material for specific purposes helped us to make presentations, knowledge sharing, and toolkit development, which formed part of the overall program collateral. While FlevyPro contains resource material that any consultancy, project or delivery firm must have, it is an essential part of a small firm or independent consultant's toolbox."

– Michael Duff, Managing Director at Change Strategy (UK)

"As a consulting firm, we had been creating subject matter training materials for our people and found the excellent materials on Flevy, which saved us 100's of hours of re-creating what already exists on the Flevy materials we purchased."

– Michael Evans, Managing Director at Newport LLC

"FlevyPro has been a brilliant resource for me, as an independent growth consultant, to access a vast knowledge bank of presentations to support my work with clients. In terms of RoI, the value I received from the very first presentation I downloaded paid for my subscription many times over! The quality of the decks available allows me to punch way above my weight – it's like having the resources of a Big 4 consultancy at your fingertips at a microscopic fraction of the overhead."

– Roderick Cameron, Founding Partner at SGFE Ltd

SELECT CUSTOMERS

Since 2012, we have provided best practices to over 5,000 businesses and organizations of all sizes across the world—in over 130 countries. Below is just a very small sample of our customer base.

Did you know?

The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

CUSTOMERS ALSO BOUGHT THESE DOCUMENTS

Market Overview: Multiple Myeloma 27-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer	Market Overview: Gastric Cancer 27-slide PowerPoint deck $299.00 Author: pharmzolgas Healthcare Cancer	Market Overview: Colorectal Cancer 26-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer	Market Overview: Breast Cancer 29-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer
Healthcare Business Capability Model 1-page PDF document $30.00 Author: R Bradley Consulting Healthcare	Pharma Launch Plan 57-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Healthcare Go-to-Market Strategy 65-slide PowerPoint deck $49.00 Author: PPT Lab Healthcare	Lean Healthcare 180-slide PowerPoint deck $79.00 Author: Operational Excellence Consulting Healthcare
Pharma Field Force Effectiveness Guide 211-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Pharma Marketing Plan 2.0 277-slide PowerPoint deck $199.00 Author: BigPharma2000 Healthcare	Pharma Brand Plan 39-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Pharma Brand Building 183-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare